library.onepin.app/masteron-enanthate-drostanolone-enanthate Peptide Education Library
Education only, not medical advice 21+ Every dose is an example to finalize with a licensed provider
Hormonal Anabolic-Androgenic SteroidNot FDA-approved · research compoundControlled substance

Masteron Enanthate (Drostanolone Enanthate)

Drostanolone Enanthate · Mast E

200mg/week – 400-600 mg IM 1-2x weekly
InjectableDHT DerivativeNon-AromatizableLong-Ester

Drostanolone enanthate is a long-ester injectable anabolic-androgenic steroid derived from dihydrotestosterone (DHT). It is the enanthate-esterified form of drostanolone (the original Masteron was drostanolone propionate). This ester extension gives it a plasma half-life of approximately 7-10 days, allowing 1-2 injections per week versus the EOD injections required by the propionate form.

Quick Start
Route
IM (intramuscular)
Start low
200mg/week IM
Frequency
1-2x weekly
Timing
No fasting required

Split weekly total into 2 injections (e.g., Monday/Thursday) for stable blood levels given the 7-10 day half-life. Compatible with long-ester testosterone and other oil-based AAS in the same syringe. Plan a 3-4 week washout after the last injection.

Start here. Every protocol below is ordered lowest-first. Begin at the smallest effective dose, hold about a week to assess tolerance, and step up only if needed.

Tiered Protocols · lowest first
Conservative start
200mg/week · IM (intramuscular) · 1-2x weekly
conservative starter
200mg/week
1-2x weekly
Research
Metastatic Breast Cancer (studied as propionate ester)
100 mg · IM · 3x weekly
human clinical trial · Talley et al. 1973 (Cancer 32(2):315-320, PMID 4579091)
100 mg
3x weekly
Expert
Cosmetic Hardener
400-600 mg · IM · Weekly
anecdotal · community
Derivative of DHT. Highly androgenic; used when body fat is already very low (<10%) to create a dry, hard look. Blunts estrogenic side effects from testosterone.
400-600 mg
Weekly
01

How it works

Drostanolone binds the androgen receptor (AR) with moderate affinity and drives protein synthesis and nitrogen retention, with a strong preference for lean tissue. As a DHT derivative, it does not aromatize to estrogen and has no intrinsic estrogenic activity.

It exhibits mild aromatase-inhibition activity - competing at the aromatase enzyme with other aromatizable androgens to reduce estrogen conversion. This makes it a useful adjunct in testosterone-based cycles where estrogen control is needed. It also displaces testosterone from sex-hormone binding globulin (SHBG), raising free testosterone.

The enanthate ester is cleaved by plasma esterases to release free drostanolone, with a plasma half-life of ~7-10 days and peak serum levels 3-5 days post-injection. It suppresses endogenous testosterone via HPT-axis feedback (less aggressively than 19-nor compounds). A testosterone base is standard.

02

What to expect

Early
Days 1–7

First 2-3 weeks: slow onset, subtle drying effect. Libido often improves (free testosterone rise from SHBG displacement).

Mid
Weeks 2–4

Weeks 4-8: steady state, peak hardness and conditioning effect. Vascularity noticeably increases.

Later
Weeks 4–12

Weeks 10-16: sustained gains. Extended cycles need careful monitoring of lipids, blood pressure, and hair/skin effects.

03

Evidence

HumanPresent
AnimalPresent
In-vitroPresent

References for this compound are being re-checked against their source records. We are not showing them until each one is confirmed to support the claim it sits under.

04

Side effects & safety

Commonly reported

  • Accelerated hair loss in genetically predisposed users
  • Oily skin and acne
  • Suppression of endogenous testosterone
  • Lipid shift (HDL drop, LDL rise)
  • Injection site soreness (less than propionate due to fewer injections)

Less common & notes

  • Increased aggression or libido, mood changes, elevated blood pressure.
  • Women: significant virilization risk at any meaningful dose - generally contraindicated in women.
  • Rare: severe lipid shifts, cardiac strain with prolonged high-dose cycling.
05

Pharmacokinetics

Illustrative plasma concentration · 38 d
Half-life
7-10 days
Peak · Tmax
3-5 days

Post-injection

Elimination
3-4 weeks
Bioavailability
~100%

IM (oil depot)

Duration of action
7-10 days

Per injection - supports 1-2x weekly dosing

Clearance

Hepatic metabolism. Renal excretion of metabolites.

Storage. Store at controlled room temperature (20-25°C / 68-77°F). Protect from light. Oil-based solution - do not refrigerate or freeze. Draw with a larger gauge needle and inject with a smaller one (18G draw, 23-25G inject). Keep out of reach of children and in a locked location - Schedule III controlled substance in the United States.

06

Regulatory status

Schedule III controlled substance in the United States under the Anabolic Steroids Control Act of 1990. Never FDA-approved (only drostanolone propionate was, and that was discontinued in the late 1990s). No legitimate pharmaceutical source exists for this ester. Possession or distribution without a valid prescription is a federal offense in the United States.

Put it to work

Calculate, log & track

Open Masteron Enanthate (Drostanolone Enanthate) straight into OnePin with your vial and dose pre-filled, then let it handle the syringe math and remind you before the vial runs out.

Open Masteron Enanthate (Drostanolone Enanthate) in the app →

Go deeper

The guide & community

The complete Masteron Enanthate (Drostanolone Enanthate) walkthrough, real protocol discussion and coaching live inside the BlessUp community on Skool.

Join the community ↗
Open in app Community

Track it in OnePin. Log vials, draws, and protocols in the app.